Company intelligence / Profile preview

Reportable

United Statesreportable.co ↗
Ownership
Private
Development stage
Other
01

Overview

Reportable provides customized media and scientific literature monitoring services for life sciences companies. Its Life Science Monitoring product delivers daily digests and real-time alerts summarizing news coverage, social media mentions, scientific manuscripts, patent filings/applications, and clinical trial updates. The service leverages artificial intelligence from NewsRx to generate comprehensive yet digestible summaries tailored to the needs of biotech/pharma/diagnostics/device/research tool organizations.

Industry
Biomedical IT and Biomedical Data Platforms
02

Partnerships

NewsRx

Beyond the preview

Go deeper on Reportable.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reportable.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call